2021 PRODUCT THEATRES
Friday, April 9, 2021
09:00 – 10:00am EDT
Reflections on Clearance Examination of Switching Data with SKYRIZI for Adults with Moderate to Severe Plaque Psoriasis
This is an independent non-accredited Product Theatre sponsored by AbbVie
Learn more about a treatment that may help your appropriate atopic dermatitis patients with uncontrolled moderate-to-severe atopic dermatitis.
Learning objectives
- Understand the treatment goals of patients with moderate to severe plaque psoriasis
- Review the results from the UltIMMa-1, -2, LIMMitless, and IMMvent trials
- Explore subanalyses of treatment responses after switching to SKYRIZI® from HUMIRA® (adalimumab) or Stelara® (ustekinumab)
Speaker
Dr. Jerry Bagel, MD
Dr. Bagel is a nationally recognized expert in the treatment of psoriasis and is regularly invited to speak across the country and internationally about this medical condition and its treatment. Dr. Bagel has been named a Top Doctor in the Castle Connolly Medical Top Doctors of the New York Metro Area every year from 2001-2015. He was named a 2005 New Jersey Top Doctor by New Jersey Life; a Best Doctor in New Jersey by New Jersey Monthly in 2001 and 2003; and received a Patients’ Choice award in 2008 as well as in Inside Jersey in 2013 and 2015. He is a four term member of the medical advisory board of the National Psoriasis Foundation. Dr. Bagel is an Editor of Practical Dermatology and the Assistant Editor of Psoriasis Forum. He has published extensively on the topic of psoriasis in such journals as The Journal of the American Academy of Dermatology and The Journal of Drugs & Dermatology. Dr. Bagel loves spending his free time at the beach, watching the Mets and enjoying great cuisine!
Friday, April 9, 2021
10:15 – 11:15am EDT
A Treatment Option for Patients with Uncontrolled Moderate-to-Severe Atopic Dermatitis
This is an independent non-accredited Product Theatre sponsored by Regeneron and Sanofi Genzyme
Examination of Switching Data with SKYRIZI for Adults with Moderate to Severe Plaque Psoriasis.
Speaker
Ben Lockshin, MD, FAAD
Assistant Professor, Georgetown University
Department of Dermatology
Director of Clinical Trials Center at US Dermatology Partners Washington, DC
Friday, April 9, 2021
11:30 – 12:30pm EDT
Oat: Yesterday, Today and Beyond
This is an independent non-accredited Product Theatre sponsored by AVEENO® – United States and AVEENO® – Canada
Examination of Switching Data with SKYRIZI for Adults with Moderate to Severe Plaque Psoriasis.
Learning Objectives:
- Identify the components and the multifaceted benefits of colloidal oatmeal and its effect on the moisture barrier
- Recognize the clinical research highlighting the benefits of colloidal oatmeal in various skin conditions such as xerosis, eczema, mild psoriasis, skin of colour and oncodermatology
Speaker
John Kraft, HBSc, MD, FRCPC
Dr. John Kraft is a board-certified dermatologist who practises at Lynde Institute for Dermatology in Markham. He is a member of the Canadian Dermatology Association where he has served on the Membership and Awards Committee. Dr. Kraft is a GTA Regional Representative for the Dermatology Association of Ontario. He is also a Dermatology Examiner for the Royal College. He is a reviewer for the Journal of Cutaneous Medicine and Surgery.
Dr. Kraft completed his HBSc (0T2), Medical Degree (0T6) and Residency in Dermatology at the University of Toronto in 2011 where he served as Chief Resident.
Dr. Kraft acts as an investigator for many clinical trials including those for novel skin therapeutics at Lynderm Research and Probity Research. He has published papers in peer-reviewed journals and has spoken at international and national dermatology scientific conferences.
Dr. Kraft enjoys teaching medical students and resident physicians from across Ontario and has won the Markham Family Medicine Teaching Unit Award for Teaching Excellence in 2014 and 2017.
Moderator
Janne Jorge
Senior Manager, Strategic Healthcare Partnerships
Johnson & Johnson Inc.
Friday, April 9, 2021
5:00 – 6:00pm EST
Understanding the JAK/STAT Pathway and Burden of Atopic Dermatitis
This is an independent non-accredited Product Theatre sponsored by Pfizer
Learning Objectives:
- REVIEW disease state and burden of atopic dermatitis (AD)
- DISCUSS integral components in the pathophysiology of AD
- DESCRIBE role of the JAK/STAT pathway in AD
Speaker
Jonathan Silverberg, MD
Dr. Jonathan Silverberg is an associate professor of dermatology at George Washington University in Washington, where he is also director of clinical research and contact dermatitis.
Dr. Silverberg’s clinical subspecialty is inflammatory skin disease, particularly atopic dermatitis and contact dermatitis. His research interests include comorbidities and burden of itch and inflammatory skin disease, evidence-based dermatology, patient-reported outcomes, and dermatoepidemiology, as well as health services research, drug development, clinical trial design, and biomarkers. He has published more than 600 peer-reviewed articles, abstracts, and book chapters, and has appeared frequently on the pages of Dermatology News.
Saturday, April 10, 2021
8:00 – 9:00am EDT
For Patients With Plaque Psoriasis: an Oral Non-Biologic Therapy with Data in Special Areas
This is an independent non-accredited Product Theatre sponsored by Amgen
Speaker
David Altman, MD
Dr. Altman is an expert in general Dermatology and dermatologic laser surgery. He pursued undergraduate studies at the University of Michigan, and then continued at the University of Michigan for medical school. He completed a year of Internal Medicine training at Northwestern University in Chicago, then finished his residency in Dermatology at Henry Ford Hospital in Detroit. Dr. Altman is a board certified dermatologist.
Dr. Altman is the chief of the division of Dermatology at St. John’s Macomb hospital in Warren Michigan, and is part of the teaching faculty for the St. Joseph’s Mercy, Livingston, Dermatology residency training program and is a Clinical Assistant Professor at the Michigan State University School of Medicine.
He is a member of the consulting staff at Beaumont Hospital, Royal Oak, Harper Hospital and St. Joseph’s Mercy Hospital in Ann Arbor.
Dr. Altman is a past executive board member of the Michigan Dermatological Society having already served as the President of that Society. He is the author of many academic publications and presentations as well as text book chapters . Dr. Altman has been named to numerous “Best Doctor” and “Top Doctor” lists, including the Hour Magazine of Detroit list for many consecutive years.
Dr. David Altman practices at the Warren Center Location of the Midwest Center for Dermatology Cosmetic Surgery.
Sunday, April 11, 2021
8:00 – 9:00am EDT
Reactive versus proactive approaches in the long-term topical management of psoriasis, and the role of retinoids in prolonging treatment effect.
This is an independent non-accredited Product Theatre sponsored by Bausch Health, Canada Inc.
Program Objectives:
After this session participants will:
- Understand the HP/Taz data regarding maintenance of effect post-treatment (remission) and the role of retinoids in prolonging treatment effect,
- Understand the calcipotriene/betamethasone dipropionate foam maintenance therapy data,
- Have an appreciation of the benefits of remission and a reactive treatment approach for their patients.
Faculty
Leon Kircik, MD, FAAD
Leon Kircik, MD is a Board Certified Dermatologist who graduated with AOA Honors from State University of New York at the Health Sciences Center at Brooklyn after completing his undergraduate work with Phi Beta Kappa at New York University. He completed a Mohs Micrographic Surgery and Cutaneous Oncology Fellowship under the auspices of Dr. Frederick Mohs at the University of Wisconsin after completing his dermatology residency at State University of New York in Buffalo.
He currently teaches as Clinical Professor of Dermatology at Icahn School of Medicine at Mount Sinai Medical Center in New York City and Associate Clinical Professor of Dermatology at Indiana University Medical Center in Indianapolis, IN. Dr. Kircik is also the Medical Director of DermResearch, PLLC , Physicians Skin Care, PLLC and Skin Sciences, PLLC in Louisville, Kentucky. Dr Kircik is also the president and founder of International Dermatology Education Foundation (IDEF) which is a non- profit organization with the goal of promoting dermatologic disease awareness and education globally. He has been the principal investigator of numerous clinical trials for psoriasis, acne, rosacea, atopic dermatitis, skin cancers, and actinic keratosis, just to name a few.
Faculty
Catherine Maari, MD
Our chair, Dr. Catherine Maari graduated in Medicine from McGill University. She completed her residency training in dermatology at the University of Montreal and her postdoctoral fellowship in pediatric dermatology at the University of California in San Diego.
Dr. Maari is an Associate Clinical Professor at the Faculty of Medicine at the University of Montreal and currently practices dermatology at the University of Montreal teaching hospital (CHUM) and Saint-Justine Hospital.
Dr. Maari is actively engaged in research. She is an investigator at Innovaderm, where she has been involved in numerous clinical studies in various areas of dermatology, including psoriasis, atopic dermatitis, acne and facial wrinkles.